Weed, Inc.

BUDZ Biotech & pharma

Develops cannabis-derived compounds for medical use.

Jun 2026Revenue $0.00/yrExpenses $1.05M/yr
No trendCash runway ≈ 1 months from Jun 2026
Figures by year

When will Weed be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $1.05M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$0.00$1.33M−$1.33M
Dec 2024$0.00$530K−$530K
Dec 2023$0.00$771K−$771K
Dec 2022$0.00$1.51M−$1.51M
Dec 2020$0.00$4.08M−$4.08M
Dec 2019$0.00$27.4M−$27.4M
Dec 2018$0.00$28.4M−$28.4M
Dec 2017$0.00$2.38M−$2.38M